Exercise of Stock Options and Total Voting Rights
Source: RNS
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.
15th November 2022
Tekcapital plc
("Tekcapital" or the "Company")
Exercise of Stock Options and Total Voting Rights
Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products from investing in university technology that can improve people's lives, is pleased to announce that the Company has received notice from Konrad Dabrowski (Non-board CFO) and Max Inglis (General Counsel) to exercise their options to subscribe for 1,100,000 ordinary shares of 0.4 pence each in the Company ("Ordinary Shares") at an exercise price of 7.83p per new Ordinary Share. The notice was accepted and having received the appropriate payment the Company has accordingly issued and allotted the 1,100,000 new ordinary shares (the "Option Shares").
|
Executive |
Existing no. of options |
Option Shares Exercised |
Remaining Share Options Held |
|
Shareholding on Admission |
Resultant percentage shareholding |
|
Mr. Max Inglis |
2,000,000 |
100,000 |
1,900,000 |
|
1,625,000 |
1.08% |
|
Mr. Konrad Dabrowski |
3,000,000 |
1,000,000 |
2,000,000 |
|
1,228,000 |
0.8% |
Application has been made for the Option Shares to be admitted to trading on the London Stock AIM (the "Admission"). It is expected that Admission will become effective on or around 18th November 2022.
Following the issue of the Option Shares, which on Admission will rank pari passu with the existing ordinary shares, the total number of ordinary shares in issue with voting rights in the Company will be 150,692,328. There are no shares held in treasury.
The above figure of 150,692,328 may therefore be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them are set out below pursuant to the EU Market Abuse regulation.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated |
||||||||||
|
a)
|
Name |
1. Max Inglis (General Counsel) 2. Konrad Dabrowski (CFO) |
|||||||||
|
2
|
Reason for the notification |
||||||||||
|
a)
|
Position/status
|
1. General Counsel 2. Chief Financial Officer |
|||||||||
|
b)
|
Initial notification / Amendment |
Initial notification |
|||||||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
|
a)
|
Name
|
TEKCAPITAL PLC |
|||||||||
|
b) |
LEI |
213800GOJTOV19FIFZ85 |
|||||||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||||||
|
a)
|
Description of the financial instrument, type of instrument Identification code |
Options over Ordinary Shares of 0.4p each
ISIN: GB00BKXGY798
|
|||||||||
|
b) |
Nature of the transaction |
Exercise of options over new ordinary shares of 0.4 pence each in the Company |
|||||||||
|
c)
|
Price(s) and volume(s)
|
|
|||||||||
|
d)
|
Aggregated information - Aggregated volume - Price
|
|
|||||||||
|
e)
|
Date of the transaction
|
14th November 2022 |
|||||||||
|
f)
|
Place of the transaction
|
Outside a trading venue |
|||||||||
LEI: 213800GOJTOV19FIFZ85
About Tekcapital plc
Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.
For further information, please contact:
|
Tekcapital Plc |
|
Via Flagstaff IR |
|
Clifford M. Gross, Ph.D. |
|
|
|
|
|
|
|
SP Angel Corporate Finance LLP (Nominated Adviser and Broker) |
|
+44 (0) 20 3470 0470 |
|
Richard Morrison / Charlie Bouverat (Corporate Finance) Rob Rees (Corporate Broking) |
|
|
|
|
|
|
|
Flagstaff Strategic and Investor Communications |
|
+44 (0) 20 7129 1474 |
|
Tim Thompson / Andrea Seymour / Fergus Mellon |
|
|
This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialise, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Tekcapital neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
